RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
Condition(s):Atrial FibrillationLast Updated:July 14, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Atrial FibrillationLast Updated:July 14, 2022Recruiting
Condition(s):Atrial FibrillationLast Updated:May 2, 2018Completed
Condition(s):Ventricular Tachycardia; Wide QRS TachycardiaLast Updated:April 6, 2016Terminated
Condition(s):ArrhythmiasLast Updated:June 28, 2018Withdrawn
Condition(s):Cardiac; Dysrhythmia, Postoperative; Congenital Heart SurgeryLast Updated:March 15, 2022Not yet recruiting
Condition(s):Prostate CancerLast Updated:February 4, 2021Completed
Condition(s):Atrial FibrillationLast Updated:June 11, 2015Completed
Condition(s):Ventricular Tachycardia; Ventricular ArrhythmiaLast Updated:November 17, 2015Terminated
Condition(s):Atrial Fibrillation; Tachycardia, Ventricular; Brugada SyndromeLast Updated:December 15, 2010Completed
Condition(s):Psychotic Disorders; Depressive Disorder, Major; Bipolar DisorderLast Updated:May 24, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.